Literature DB >> 4575851

Transfer factor therapy in immune deficiency states.

A S Levin, L E Spitler, H H Fudenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4575851     DOI: 10.1146/annurev.me.24.020173.001135

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  10 in total

Review 1.  Immunological reactions in heart disease.

Authors:  M Lessof
Journal:  Br Heart J       Date:  1978-03

2.  Editorial: Transfer factor.

Authors: 
Journal:  Br Med J       Date:  1974-05-25

3.  Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.

Authors:  N H Axelsen; C H Kirkpatrick; R H Buckley
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

4.  Immunologic specificity of transfer factor.

Authors:  K S Zuckerman; J A Neidhart; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

5.  In vitro properties of leukocyte dialysates containing transfer factor.

Authors:  M S Ascher; W J Schneider; F T Valentine; H S Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  Studies on the transfer factor of delayed hypersensitivity. Effect of dialysable leucocyte extracts from people of known tuberculin sensitivity on the migration of normal guinea-pig macrophages in the presence of antigen.

Authors:  M R Salaman
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

7.  [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].

Authors:  C P Sodomann; G Maerker-Alzer; K Havemann; C Dienst; H Schultz; D Mitrenga; K Schumacher; G A Martini
Journal:  Klin Wochenschr       Date:  1979-09-03

8.  Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.

Authors:  S Jain; H C Thomas; S Sherlock
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

9.  Disseminated coccidioidomycosis: clinical, immunologic and therapeutic aspects.

Authors:  D Danoff; Z M Munk; B Case; M Finlayson; P Gold
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

10.  Immunotherapy of coccidioidomycosis.

Authors:  A Catanzaro; L Spitler; K M Moser
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.